Emerging Drug Discovery Technologies: Building competitive advantage through lab-on-a-chip, nanotechnology and RNAi

Abstract

Emerging Drug Discovery Technologies: Building competitive advantage through lab-on-a-chip, nanotechnology and RNAi, is a new report which provides an in-depth analysis of three technological innovations that are being heralded to revolutionize the drug discovery process by rapidly expediting drug discovery research. This report focuses on lab-on-a-chip (LOC) devices, nanotechnology and RNA interference drug discovery technologies that are increasingly being used to identify novel drug targets and to successfully reduce R&D timelines. This report also provides: in-depth analysis of the market forces, current and future technological advances, detailed company profiles, eight year forecasts of market size for LOC devices, nanotechnology in, drug discovery and RNA interference technologies and therapeutics. Incorporate the most innovative technologies into your drug discovery process, significantly reduce R&D timelines and build a unique competitive edge with the help of this latest report.